← All organizations
Highest phase reached
Phase 4
First clinical trial
Oct 1, 2000First marketed drug
Jun 1, 1950First NDA
Jun 1, 1950Last known activity
Jul 3, 2024
Acquired by Graceway → Medicis → Bausch Health Companies on Jan 1, 2006
Timeline
1900s
- Jan 1, 1902
3M— Founded
1950s
- May 10, 1957
orphenadrine hydrochloride— NDA Organization
- Aug 14, 1959
diethylpropion hydrochloride— NDA Secondary Org
2000s
- Jan 1, 2006
Graceway— Acquired By
2010s
- Dec 11, 2012
- Nov 4, 2016
fentanyl— Marketing Organization
Drugs by trial phase (20 distinct, 36 trials)
Phase 4 (7 own, 0 via acquisition)
Phase 3 (5 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Approved for
- Acromegaly
- Anemia
- Arthritis, Psoriatic
- Arthritis, Rheumatoid
- Bacterial Infections
- Basal Cell Carcinoma
- Colitis, Ulcerative
- Condylomata Acuminata
- Constipation
- Cough
- Keratosis, Actinic
- Multiple Sclerosis
- Muscle Cramp
- Musculoskeletal Pain
- Pain
- Prostatic Neoplasms
- Psoriasis
- Spondylitis, Ankylosing
- Urinary Tract Infections
Marketed drugs (23)
- phenylephrine
- heparin
- theophylline
- ergoloid mesylate
- ethanol
- imiquimod
- hexamethylenetetramine
- epinephrine
- rauwolfia alkaloids
- radiolabeled albumin technetium Tc-99m albumin colloid kit
- fentanyl
- isopropyl alcohol
- albuterol
- iodine povacrylex
- diethylpropion hydrochloride
- orphenadrine hydrochloride
- ytterbium (169yb) dtpa
- ergotamine
- chlorhexidine
- hexachlorophene
Recent trials (39)
- NCT05745467CollaboratorPhase 4Jul 3, 2024
- NCT05983874CollaboratorPhase 1Nov 30, 2023
- NCT04510402CollaboratorPhase 1/Phase 2Aug 31, 2020
- NCT04756154Lead sponsorPhase 3Jul 6, 2020
- NCT04210505CollaboratorPhase 4Mar 2, 2020
- NCT04601103Lead sponsorN/AJan 6, 2020
- NCT03246581Lead sponsorPhase 1Jul 13, 2017
- NCT03246581Study chairPhase 1Jul 13, 2017
- NCT03681990Lead sponsorPhase 2Jun 6, 2017
- NCT03155204Study chairEarly Phase 1Apr 25, 2017
- NCT03155204Lead sponsorEarly Phase 1Apr 25, 2017
- NCT03015259Lead sponsorPhase 3Jan 2, 2017
- NCT03155178Lead sponsorPhase 2Dec 5, 2016
- NCT03302065Study chairPhase 1May 31, 2016
- NCT03302065Lead sponsorPhase 1May 31, 2016
Details
- Founded
- St Paul, MN, US Jan 1, 1902
- First NDA
- Jun 1, 1950
- Last known activity
- Jul 3, 2024
Designations held
- Priority review